Volume 8 - Issue 12 - December, 2000
Commentary Response: Primary Angioplasty is Now the Benchmark for the Treatment of AMI and Needs Broader Access
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 2785 reads
Primary PTCA vs. Fibrinolytic Therapy
Dr. Ryan™s contention that there is no conclusive evidence that primary PTCA is superior to fibrinolytic therapy in acute myocardial infarction (AMI) is counter to a large volume of literature1-4 (see also Table 1 and Figure 2 of our article). More recent evidence includes the randomized STOP AMI study5, which found that primary PTCA with stents and abciximab yielded dramatically superior outcomes in patients with AMI compared to alteplase, and the just-announced randomized C-PORT trial at community hospitals without on-site cardiac surgery, whic
Primary Angioplasty at Community Hospitals in the 21st Century: A Commentary
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 3466 reads
In an effort to maintain a balanced national sense on this issue that has cardiologists divided in their opinions, it seems critically important to make the nurses, technicians and other healthcare professionals who constitute the infrastructure so essential to the performance of interventional procedures (PCI) aware of more moderate views and why the solution as proposed by Wharton et al is likely the wrong one.
First of all, the national bodies of organized cardiology that set standards of practice and promulgate guidelines have always intended that these procedures, the outcomes of which a
Management of Access Site and Systemic Complications of Percutaneous Coronary and Peripheral Interventions
- Thu, 12/4/08 - 11:20am
- 0 Comments
- 7272 reads
Abstract:
The role of endovascular therapy for the treatment of coronary and peripheral vascular diseases (including carotid, renal and lower extremity arteries) is expanding. The steady growth in the volume of endovascular procedures is likely to result in an absolute increase in the incidence of procedural complications. Knowledge of common and specific procedural complications and their management are critical to successful outcomes. Complications can be classified as (i) access site-related and (ii) systemic.
Reprinted with permission from The Journal of Invasive Cardiology 2008;20:4
